Hepatic dysfunction is commonly encountered during total parenteral nu
trition (TPN), but it is likely that factors other than TPN play an im
portant role. This study divides TPN patients, before TPN administrati
on, into two groups according to whether the pre-TPN liver function te
st was normal or abnormal. Among the 729 cases studied, liver function
impairment was progressively downhill in patients with abnormal pre-T
PN liver function, but liver function maintained normal in most patien
ts with normal pre-TPN liver function test. The TPN formula did not di
ffer between the two groups. Thus, TPN formula itself is probably not
a crucial causal factor for hepatic dysfunction. Instead, the etiology
of that dysfunction is more likely a result of multiple factors. From
this study, it is suggested that digestive disease, nothing per os, a
nd infections all play an important role (P < 0.001). The rates of mor
bidity, mortality, and organ failure are significantly increased in th
e group with abnormal pre-TPN liver function (P < 0.05). Aggressive tr
eatment of underlying disease and early restoration of enteral feeding
are suggested to reduce TPN-induced hepatic dysfunction.